Discovery of Tetrahydropyrazolopyrazine Derivatives As Potent and Selective MYT1 Inhibitors for the Treatment of Cancer.
JOURNAL OF MEDICINAL CHEMISTRY（2023）
Key words
Drug Target Identification
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined